Delivery Order SPE2DB22D1106-SPE2DB24FDZT5
- Not listed
- This federal contract award is a delivery order valued at $37,825.20 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with an ultimate completion date of May 28, 2025. The contract is a firm fixed-price arrangement and is not set aside for any particular business type. AmerisourceBergen Drug Corp...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The $1,217.72 fixed-price contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, to provide a comprehensive range of medical commodities, including pharmaceuticals and...
- This federal contract award, valued at $11,255.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price contract. The award is not designated as a set-aside contract, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.48, is a delivery order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The award has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies, specifically MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $12,955.78 and an ultimate completion date of November 17, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract...
- This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML medical products. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order valued at $99,737.70 and has a firm fixed price pricing type. The contract does not have a set-aside designation. The contract is associated with a larger Indefinite Delivery Contract (IDC)...
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $206,110.62, is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product. The contract has an ultimate completion date of November 6, 2024 and is structured as a firm fixed price delivery order. This award does not have a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,293.40, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of February 11, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.48, is a delivery order for the medical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML". The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Menveo 1 vial-A-C-Y-W-135-DIP 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $112,034.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price pricing type and an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDZT5Delivery Order
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The firm fixed price Delivery Order has a potential value of $7,047.30 and a completion date of February 13, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 2/12/24 |